Runway Growth Finance (RWAY) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Delivered total investment income of $33.8 million and net investment income of $14.6 million ($0.39 per share) for Q4 2024, reflecting strong portfolio performance and disciplined underwriting.
Closed the acquisition of the investment advisor by BC Partners Credit in January 2025, expanding origination channels, product set, and infrastructure for future growth.
Investment portfolio at fair value reached $1.1 billion across 56 portfolio companies and one joint venture as of December 31, 2024.
Management team averages 30+ years of experience, supporting consistent quarterly distributions and robust portfolio management.
Repurchased 3.16 million shares during 2024 under share repurchase programs.
Financial highlights
Total investment income for Q4 2024 was $33.8 million, down from $36.7 million in Q3 2024 and $39.2 million in Q4 2023.
Net investment income for Q4 2024 was $14.6 million, compared to $15.9 million in Q3 2024 and $18.3 million in Q4 2023.
NAV per share increased to $13.79 at year-end 2024, up 3% from $13.39 at the end of Q3 2024 and from $13.50 a year earlier.
Dollar-weighted average annualized yield on the debt portfolio was 14.7% for Q4 2024.
Operating expenses decreased to $19.2 million in Q4 2024 from $20.8 million in Q3 2024 and $20.9 million in Q4 2023.
Outlook and guidance
Target allocation to the BDC remains $20-$45 million per deal, with overall loan sizes ranging from $30-$150 million.
Expect continued focus on portfolio diversification and disciplined underwriting, leveraging BC Partners' scale and expertise.
Quarterly base dividend set at $0.33 per share, with a supplemental dividend up to 50% of the delta over NII per share.
No change in leverage target, which remains at 1.2-1.3x; focus on building NAV and maintaining stable dividends.
Management expects the BC Partners combination to drive near-term growth through enhanced financing solutions and increased capital deployment capacity.
Latest events from Runway Growth Finance
- Q2 2024 featured strong yields, new investments, and active capital return programs.RWAY
Q2 20249 Jul 2026 - Lower Q4 2025 income, but strong portfolio, stable dividends, and SWK acquisition drive growth.RWAY
Q4 20258 Jul 2026 - SWK acquisition expands healthcare exposure as Q1 income dips and share repurchase is launched.RWAY
Q1 20268 May 2026 - Annual meeting to elect directors and ratify Deloitte as auditor, with strong governance in place.RWAY
Proxy filing29 Apr 2026 - Shareholders will vote on two director nominees and auditor ratification at the June 2026 virtual meeting.RWAY
Proxy filing29 Apr 2026 - Q3 2024 saw $75.3M in new loans, strong yields, and a strategic adviser acquisition pending.RWAY
Q3 202414 Jan 2026 - $220M NAV-for-NAV merger boosts healthcare exposure and scale, closing by early 2026.RWAY
M&A Announcement7 Jan 2026 - Vote sought on new advisory agreement, director election, and adjournment; no fee or strategy changes.RWAY
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections and auditor ratification at the 2024 virtual meeting.RWAY
Proxy Filing2 Dec 2025